Pantel K - Search Results

1

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial.

Riethdorf S, Müller V, Zhang L, Rau T, Loibl S, Komor M, Roller M, Huober J, Fehm T, Schrader I, Hilfrich J, Holms F, Tesch H, Eidtmann H, Untch M, von Minckwitz G, Pantel K. Riethdorf S, et al. Among authors: pantel k. Clin Cancer Res. 2010 May 1;16(9):2634-45. doi: 10.1158/1078-0432.CCR-09-2042. Epub 2010 Apr 20. Clin Cancer Res. 2010. PMID: 20406831 Clinical Trial.

2

Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.

Schaller G, Fuchs I, Pritze W, Ebert A, Herbst H, Pantel K, Weitzel H, Lengyel E. Schaller G, et al. Among authors: pantel k. Clin Cancer Res. 1996 Nov;2(11):1879-85. Clin Cancer Res. 1996. PMID: 9816144

3

Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11.

Ahr A, Scharl A, Müller M, von Minckwitz G, Gätje R, Pantel K, Kaufmann M. Ahr A, et al. Among authors: pantel k. Int J Cancer. 1999 Oct 22;84(5):502-5. doi: 10.1002/(sici)1097-0215(19991022)84:5<502::aid-ijc9>3.0.co;2-x. Int J Cancer. 1999. PMID: 10502727

4

Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.

Braun S, Hepp F, Kentenich CR, Janni W, Pantel K, Riethmüller G, Willgeroth F, Sommer HL. Braun S, et al. Among authors: pantel k. Clin Cancer Res. 1999 Dec;5(12):3999-4004. Clin Cancer Res. 1999. PMID: 10632331 Clinical Trial.

5

Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.

Hosch S, Kraus J, Scheunemann P, Izbicki JR, Schneider C, Schumacher U, Witter K, Speicher MR, Pantel K. Hosch S, et al. Among authors: pantel k. Cancer Res. 2000 Dec 15;60(24):6836-40. Cancer Res. 2000. PMID: 11156375

6

ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.

Braun S, Schlimok G, Heumos I, Schaller G, Riethdorf L, Riethmüller G, Pantel K. Braun S, et al. Among authors: pantel k. Cancer Res. 2001 Mar 1;61(5):1890-5. Cancer Res. 2001. PMID: 11280743

7

MAGE-A gene expression pattern in primary breast cancer.

Otte M, Zafrakas M, Riethdorf L, Pichlmeier U, Löning T, Jänicke F, Pantel K. Otte M, et al. Among authors: pantel k. Cancer Res. 2001 Sep 15;61(18):6682-7. Cancer Res. 2001. PMID: 11559535

8

Molecular determinants of occult metastatic tumor cells in bone marrow.

Pantel K, Braun S. Pantel K, et al. Clin Breast Cancer. 2001 Oct;2(3):222-8. doi: 10.3816/CBC.2001.n.025. Clin Breast Cancer. 2001. PMID: 11899416 Review.

9

Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.

Müller V, Thomssen C, Karakas C, Eustermann I, Ramirez Porras J, Coith C, Berger J, Löning T, Jänicke F, Pantel K. Müller V, et al. Among authors: pantel k. Int J Biol Markers. 2003 Jan-Mar;18(1):13-20. doi: 10.1177/172460080301800103. Int J Biol Markers. 2003. PMID: 12699058 Free article.

10

Effects of whole body hyperthermia (41.8 degrees C) on the frequency of tumor cells in the peripheral blood of patients with advanced malignancies.

Hegewisch-Becker S, Braun K, Otte M, Corovic A, Atanackovic D, Nierhaus A, Hossfeld DK, Pantel K. Hegewisch-Becker S, et al. Among authors: pantel k. Clin Cancer Res. 2003 Jun;9(6):2079-84. Clin Cancer Res. 2003. PMID: 12796371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

677 results

Search Page

Filters